Quarterly report · Q3
8086.TEDINET S100STZ2
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥439.1bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥545.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥406.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥22.4bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥13.2bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥20.0bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥15.3bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.8bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥22.1bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥14.7bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥13.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥8.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥1.11T | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.03T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.05T | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥831.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥785.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥280.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥242.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥240.2bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥79.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥77.44 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.55 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.05 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.69 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.35 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥68.61 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.85 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.82 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.9% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥3.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥642m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | −¥200m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥54.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥54.6bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥19.8bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥345.3bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥340.3bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥5.0bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥35.4bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥96.0bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥54.2bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥41.8bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥5.3bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥48.6bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥43.9bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥1.6bn |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥490.0bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥438.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥51.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥42.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥493.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥439.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥54.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥42.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥3.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥530m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥166m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥28.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥28.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥22.5bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥318.8bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥314.2bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥30.8bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥70.3bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥53.6bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥16.8bn |
| jpcrp040300-q3r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥42.6bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥38.0bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.5bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥431.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥405.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥25.9bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥35.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥434.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥406.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥28.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥35.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 445
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7763300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0453 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 7763300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 7763300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0453 | |
| Cash and deposits | Prior1YearInstant | 89678000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 79425000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 160271000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 182453000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 137774000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 151726000000 | JPY |
| Work in process | Prior1YearInstant | 17427000000 | JPY |
| Work in process | CurrentQuarterInstant | 20996000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 52592000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 57180000000 | JPY |
| Other ca | Prior1YearInstant | 35701000000 | JPY |
| Other ca | CurrentQuarterInstant | 48968000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -4157000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -4745000000 | JPY |
| Current assets | Prior1YearInstant | 489289000000 | JPY |
| Current assets | CurrentQuarterInstant | 536005000000 | JPY |
| Buildings and structures | Prior1YearInstant | 287677000000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 332365000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | Prior1YearInstant | -147531000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | CurrentQuarterInstant | -155295000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 140145000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 177069000000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 360642000000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 403308000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | Prior1YearInstant | -265162000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | CurrentQuarterInstant | -284413000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 95480000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 118894000000 | JPY |
| Land | Prior1YearInstant | 47123000000 | JPY |
| Land | CurrentQuarterInstant | 47617000000 | JPY |
| Lease assets ppe | Prior1YearInstant | 35947000000 | JPY |
| Lease assets ppe | CurrentQuarterInstant | 37750000000 | JPY |
| Accumulated depreciation lease assets ppe | Prior1YearInstant | -13115000000 | JPY |
| Accumulated depreciation lease assets ppe | CurrentQuarterInstant | -15782000000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 22831000000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 21967000000 | JPY |
| Construction in progress | Prior1YearInstant | 103336000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 82039000000 | JPY |
| Other ppe | Prior1YearInstant | 89858000000 | JPY |
| Other ppe | CurrentQuarterInstant | 100948000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | Prior1YearInstant | -66224000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | CurrentQuarterInstant | -73483000000 | JPY |
| Other net ppe | Prior1YearInstant | 23633000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |